Skip to main content

AGC Pharma Chemicals will be attending the 54th Organic Process Research and Development Conference in Lisbon from September 29 to October 1, 2025. This premier gathering of process chemists and R&D professionals offers a rich agenda of technical insights and knowledge sharing.

Our experts will be present to engage with industry peers and discuss how we support pharma companies in process development, scale-up, and technology transfer.

With expertise in complex synthesis and API production, our capabilities are designed to meet the challenges of modern drug development under the highest quality and safety standards.

We’re looking forward to connecting with key players in the R&D community and gaining valuable insights to continue driving innovation in our services.

Latest News

AGC PharmaAll of ArticlesCDMO ProcessesThe Key Role of Project Management in a CDMO
11th December 2025

The Key Role of Project Management in a CDMO

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
NoticiasAGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros
25th November 2025

AGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros

AGC Pharma Chemicals inaugurated its new state-of-the-art manufacturing plant in Malgrat de Mar, Barcelona, representing an investment of over 100 million euros. The new facility marks a key milestone in…
NoticiasAGC Pharma Chemicals receives a platinum medal from EcoVadis, placing among the Top 1% in sustainability worldwide
1st November 2025

AGC Pharma Chemicals receives a platinum medal from EcoVadis, placing among the Top 1% in sustainability worldwide

EcoVadis, the global reference in corporate sustainability ratings, has once again recognized our company with the Platinum Medal in Europe site, placing us among the top 1% of the most…